Lilly’s legal offensive against compounders of its popular weight loss drugs hits another snag in court.
India’s anti-obesity pharmaceutical market is valued at ₹859 crore, having recorded a five-fold increase over five years with ...
A statewide probe in Rajasthan has uncovered massive lapses in drug regulation, revealing that substandard and fake medicines ...
Eli Lilly's weight-loss drug Mounjaro is rapidly climbing the ranks in the Indian pharmaceutical market, nearing ...
A silent health crisis is unfolding in Rajasthan. Hundreds of medicines failed quality tests, many after reaching patients.
India's pharmaceutical market rose 7.3% year-on-year in September to ₹20,886 crore, driven by robust growth in antidiabetic, ...
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 6, 2025 (HealthDay News) — An approved pill for Alzheimer’s disease might ...